Pharming Group N.V.
Close on Oct 19, 2026
- Market cap
- –
- P/E (TTM)
- 2277.5
- Dividend yield
- –
Earnings
Quarterly results announced on Form 8-K, Item 2.02
No earnings releases found
Pharming has not filed an earnings release (Form 8-K, Item 2.02) that we could match to a fiscal quarter.
Press releases
Announcements Pharming filed with the SEC
Current report on Form 6-K
Event dated Oct 22, 2026, from SEC EDGAR
Current report on Form 6-K
Event dated Oct 14, 2026, from SEC EDGAR
Current report on Form 6-K
Event dated Sep 29, 2026, from SEC EDGAR
Current report on Form 6-K
Event dated Sep 25, 2026, from SEC EDGAR
Current report on Form 6-K
Event dated Sep 22, 2026, from SEC EDGAR
Current report on Form 6-K
Event dated Sep 11, 2026, from SEC EDGAR
Current report on Form 6-K
Event dated Aug 13, 2026, from SEC EDGAR
Current report on Form 6-K
Event dated Jul 30, 2026, from SEC EDGAR
Current report on Form 6-K
Event dated Jun 4, 2026, from SEC EDGAR
Current report on Form 6-K
Event dated May 28, 2026, from SEC EDGAR
Current report on Form 6-K
Event dated May 22, 2026, from SEC EDGAR
Current report on Form 6-K
Event dated May 7, 2026, from SEC EDGAR
Current report on Form 6-K
Event dated May 7, 2026, from SEC EDGAR
Current report on Form 6-K
Event dated Apr 16, 2026, from SEC EDGAR
Current report on Form 6-K
Event dated Apr 2, 2026, from SEC EDGAR